Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
Werte in diesem Artikel
MINNEAPOLIS, Oct. 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, November 5, 2025, at 8:00 a.m. CST to review its first quarter fiscal 2026 financial results.
Access to the discussion may be obtained as follows:
Time: | 8:00 a.m. CST |
Date: | November 5, 2025 |
Dial-in: | 1-800-274-8461 or 1-203-518-9814 (for international callers) |
Conference ID: | TECHQ1 |
Webcast: |
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11160247.
The replay will be available from 11:00 a.m. CST on Wednesday, November 5, 2025, until 11:00 p.m. CST on Friday, December 5, 2025.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at LinkedIn, X, or YouTube.
Contact:
David Clair, Vice President, Investor Relations
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-november-5-2025-to-announce-first-quarter-fiscal-2026-financial-results-302580833.html
SOURCE Bio-Techne Corporation
Ausgewählte Hebelprodukte auf Bio-Techne
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Bio-Techne
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Bio-Techne Aktie News
Bio-Techne Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Bio-Techne nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.10.18 | Bio-Techne Hold | Craig Hallum | |
| 18.01.17 | Bio-Techne Buy | Deutsche Bank AG | |
| 21.01.15 | Bio-Techne Outperform | Robert W. Baird & Co. Incorporated |
